Canada
· Delayed Price · Currency is CAD RepliCel Life Sciences Statistics
Total Valuation
TSXV:RP has a market cap or net worth of CAD 209,325. The enterprise value is 1.58 million.
| Market Cap | 209,325 |
| Enterprise Value | 1.58M |
Important Dates
The last earnings date was Wednesday, April 30, 2025.
| Earnings Date | Apr 30, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +52.12% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 41.78M |
Valuation Ratios
The trailing PE ratio is 0.15.
| PE Ratio | 0.15 |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 1.15 |
| EV / Sales | 4.23 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.02
| Current Ratio | 0.02 |
| Quick Ratio | 0.02 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -5.92 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -148.73% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 26.65% |
| Revenue Per Employee | 353,735 |
| Profits Per Employee | 1.37M |
| Employee Count | 1 |
| Asset Turnover | 1.47 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -72.73% in the last 52 weeks. The beta is 0.96, so TSXV:RP's price volatility has been similar to the market average.
| Beta (5Y) | 0.96 |
| 52-Week Price Change | -72.73% |
| 50-Day Moving Average | 0.01 |
| 200-Day Moving Average | 0.04 |
| Relative Strength Index (RSI) | 59.22 |
| Average Volume (20 Days) | 43,160 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.04 |
Income Statement
In the last 12 months, TSXV:RP had revenue of CAD 353,735 and earned 1.37 million in profits. Earnings per share was 0.02.
| Revenue | 353,735 |
| Gross Profit | 353,735 |
| Operating Income | -574,022 |
| Pretax Income | 1.37M |
| Net Income | 1.37M |
| EBITDA | -573,346 |
| EBIT | -574,022 |
| Earnings Per Share (EPS) | 0.02 |
Balance Sheet
The company has 10,465 in cash and 1.31 million in debt, giving a net cash position of -1.30 million.
| Cash & Cash Equivalents | 10,465 |
| Total Debt | 1.31M |
| Net Cash | -1.30M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | -5.19M |
| Book Value Per Share | -0.08 |
| Working Capital | -2.25M |
Cash Flow
| Operating Cash Flow | -88,216 |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 100.00%, with operating and profit margins of -162.27% and 386.01%.
| Gross Margin | 100.00% |
| Operating Margin | -162.27% |
| Pretax Margin | 386.01% |
| Profit Margin | 386.01% |
| EBITDA Margin | -162.08% |
| EBIT Margin | -162.27% |
| FCF Margin | n/a |
Dividends & Yields
TSXV:RP does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -52.12% |
| Shareholder Yield | -52.12% |
| Earnings Yield | 652.32% |
| FCF Yield | n/a |
Stock Splits
The last stock split was on August 10, 2016. It was a reverse split with a ratio of 0.1.
| Last Split Date | Aug 10, 2016 |
| Split Type | Reverse |
| Split Ratio | 0.1 |
Scores
TSXV:RP has an Altman Z-Score of -435.16. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -435.16 |
| Piotroski F-Score | n/a |